{"id":572115,"date":"2024-12-18T00:00:00","date_gmt":"2024-12-18T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042088-medtech-transcatheter-embolization-and-occlusion-devices-market-insights-asia-pacific-2025\/"},"modified":"2026-04-14T10:03:07","modified_gmt":"2026-04-14T10:03:07","slug":"47042088-medtech-transcatheter-embolization-and-occlusion-devices-market-insights-asia-pacific-2025","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042088-medtech-transcatheter-embolization-and-occlusion-devices-market-insights-asia-pacific-2025\/","title":{"rendered":"Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific | 2025"},"content":{"rendered":"<p>The Asia Pacific\u00a0TEO\u00a0device market will experience moderate growth through 2033. This growth will be driven by the introduction and rising adoption of new devices supported by favorable clinical data. Additionally, increased access to\u00a0TEO\u00a0devices and a growing demand for\u00a0TEO\u00a0procedures among an expanding patient population will contribute to this trend. Furthermore, the increasing disease burden and the availability of enhanced diagnostic techniques facilitating earlier and more accurate detection of conditions treatable with\u00a0TEO\u00a0devices will drive growth in the market. However, ongoing cost constraints in the region will continue to pose challenges for the market.<\/p>\n<p>This Medtech 360 Report offers an in-depth analysis and comprehensive data on the\u00a0TEO\u00a0device market in the Asia Pacific region, covering the period from 2019 to 2033.<\/p>\n","protected":false},"template":"","class_list":["post-572115","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-transcatheter-embolization-and-occlusion-devices","medtech-geography-asia-pacific","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/572115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/572115\/revisions"}],"predecessor-version":[{"id":572292,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/572115\/revisions\/572292"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=572115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}